Inhibition of EZH2 alleviates SAHA-induced senescence-associated secretion phenotype in small cell lung cancer cells
Abstract Chemotherapy has been widely used in small cell lung cancer (SCLC) treatment in the past decades. However, SCLC is easy to recur after chemotherapy. The senescence of cancer cells during chemotherapy is one of the effective therapeutic strategies to inhibit the progression of cancer. Nevert...
Main Authors: | Sun-Hyok Kong, Lie Ma, Qingxia Yuan, Xiangxiang Liu, Yu Han, Weifang Xiang, Dong-Xu Liu, Yu Zhang, Jun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-08-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-023-01591-y |
Similar Items
-
NR2F2 alleviates pulmonary fibrosis by inhibition of epithelial cell senescence
by: Ruyan Wan, et al.
Published: (2024-04-01) -
Cell senescence, the senescence-associated secretory phenotype, and cancers.
by: Larissa G P Langhi Prata, et al.
Published: (2023-09-01) -
Cellular senescence primes liver fibrosis regression through Notch‐EZH2
by: Ping Song, et al.
Published: (2023-10-01) -
ISRIB inhibits the senescence of type II pulmonary epithelial cells to alleviate pulmonary fibrosis induced by silica in mice
by: Ya-Qian Li, et al.
Published: (2023-10-01) -
FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells
by: Hsiang-Hao Chuang, et al.
Published: (2022-08-01)